NEU 1.33% $20.73 neuren pharmaceuticals limited

Ann: Trading Halt, page-285

  1. 2,735 Posts.
    lightbulb Created with Sketch. 1062
    Sounds logical @TonyWAIW .

    However, as we witnesses with the Trofinetide ROW deal, Jon and the NEU Board played a long hard well negotiated game over many months and came out with a terrific result. I don't expect anything different this time should an eager acquirer appear over the next few months. It is in NEU's best interest to encourage a bidding war between several interested interested parties which I am sure there are several watching closely.

    I am sure that is why NEU has been engaging Jefferies during 2023. Jefferies has very good visibility of the sector and M&A activity which is certainly on the increase as per the video @Richo24 kindly posted yesterday.

    Post #: 71485474

    What a terrific exciting company NEU is. I just hope their products go onto be a wonderful solution for those suffering from these syndromes and provide some relief for their families.

 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
(20min delay)
Last
$20.73
Change
-0.280(1.33%)
Mkt cap ! $2.647B
Open High Low Value Volume
$20.87 $21.19 $20.70 $6.213M 297.7K

Buyers (Bids)

No. Vol. Price($)
4 5414 $20.72
 

Sellers (Offers)

Price($) Vol. No.
$20.79 335 1
View Market Depth
Last trade - 16.10pm 21/05/2024 (20 minute delay) ?
Last
$20.73
  Change
-0.280 ( 1.22 %)
Open High Low Volume
$20.99 $21.19 $20.69 94423
Last updated 15.59pm 21/05/2024 ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.